By Counterforce Health Team in Tremfya (guselkumab) —

How to Get Tremfya (Guselkumab) Covered by Aetna CVS Health in Texas: Complete 2024 Guide with Forms and Appeal Scripts

Answer Box: Getting Tremfya Covered by Aetna CVS Health in Texas

Tremfya (guselkumab) requires prior authorization from Aetna CVS Health for psoriasis, psoriatic arthritis, and ulcerative colitis. Success requires documenting moderate-to-severe disease, trials/failures of preferred biologics (like Humira or TNF inhibitors), and negative TB screening. Submit via specialist through CVS Specialty Pharmacy with complete clinical documentation. Standard approval takes 30-45 days; expedited decisions within 72 hours with urgency documentation. If denied, Texas law guarantees independent external review through the Texas Department of Insurance within 4 months.

First step today: Contact your dermatologist, rheumatologist, or gastroenterologist to initiate the prior authorization process and gather documentation of previous treatment failures.

Table of Contents

  1. Aetna CVS Health Plan Types & Coverage Differences
  2. Tremfya Formulary Status & Tier Placement
  3. Prior Authorization Requirements & Clinical Criteria
  4. CVS Specialty Pharmacy Setup Process
  5. Cost-Share Basics & Financial Assistance
  6. Step-by-Step: Fastest Path to Approval
  7. Common Denial Reasons & How to Fix Them
  8. Appeals Process in Texas
  9. Required Forms & Submission Details
  10. FAQ: Your Top Questions Answered

Plan Types & Coverage Differences

Aetna CVS Health offers different plan structures in Texas that affect how you access Tremfya and specialty care:

Plan Type Referrals for Specialists Out-of-Network Coverage Tremfya Access Notes
HMO Required from PCP Emergency only Must get referral to dermatologist/rheumatologist first
PPO Not required Yes, higher cost Direct specialist access; same PA rules apply
EPO Not required Emergency only No PCP selection needed; must use network specialists

All plan types require prior authorization for Tremfya and mandate CVS Specialty Pharmacy for dispensing. The key difference is whether you need a referral to see the specialist who can prescribe Tremfya.

Tremfya Formulary Status & Tier Placement

Tremfya sits on Tier 4 (specialty tier) of most Aetna CVS Health formularies as a non-preferred biologic. This means:

  • Higher copayments or coinsurance (typically 25-50% after deductible)
  • Mandatory prior authorization
  • Step therapy requirements (must try preferred alternatives first)
  • 30-day supply limits initially

Preferred alternatives that plans typically require you to try first include:

  • TNF inhibitors: Humira (adalimumab), Enbrel (etanercept), Remicade/Inflectra (infliximab)
  • Other IL-17/IL-23 inhibitors: Stelara (ustekinumab), Cosentyx (secukinumab), Taltz (ixekizumab)
  • Oral options: Otezla (apremilast), Sotyktu (deucravacitinib)

Verify current formulary status via Aetna's drug search tool.

Prior Authorization Requirements & Clinical Criteria

Aetna CVS Health requires comprehensive documentation for Tremfya approval:

Core Requirements for All Indications

  • Specialist prescription: Dermatologist (psoriasis), rheumatologist (psoriatic arthritis), or gastroenterologist (ulcerative colitis)
  • Diagnosis confirmation: Appropriate ICD-10 codes (L40.0 for plaque psoriasis, M07.6 for psoriatic arthritis)
  • Disease severity documentation: PASI ≥10 or ≥10% body surface area for psoriasis; active disease markers for psoriatic arthritis
  • TB screening: Negative QuantiFERON, TST, or IGRA within 6 months; chest X-ray showing no active disease

Indication-Specific Criteria

Plaque Psoriasis:

  • Moderate-to-severe disease (PASI ≥10 or ≥10% BSA)
  • Trial/failure of preferred biologic OR inadequate response/contraindication to conventional therapy (methotrexate, cyclosporine)
  • Photos or clinical documentation of severity

Psoriatic Arthritis:

  • Active disease with joint involvement
  • Trial/failure of preferred biologic/targeted synthetic DMARD OR inadequate response/contraindication to traditional DMARDs

Ulcerative Colitis:

  • Moderately-to-severely active disease
  • Some plans may not require prior biologic failure for IBD indications (verify with your specific plan)
Note: "Trial/failure" typically means 3+ months of therapy at appropriate doses with inadequate response or documented intolerance/contraindication.

CVS Specialty Pharmacy Setup Process

Aetna CVS Health mandates CVS Specialty Pharmacy for Tremfya dispensing. Here's the enrollment process:

Required Documentation

  1. Patient information: Name, DOB, address, phone/email, insurance details
  2. Prescriber details: Practice name, NPI, contact information, signature (no stamps)
  3. Prescription: Tremfya 100 mg/mL subcutaneous, dosing schedule, NDC 57894-640-11
  4. Clinical documentation: All prior authorization materials
  5. Patient authorization: Signed consent form (page 2 of enrollment form)

Submission Methods

  • Fax: (888) 267-3277 for CVS Caremark Specialty
  • Phone: (866) 752-7021 for status updates
  • Online: CVS Specialty provider portal (requires registration)

Download CVS Specialty enrollment forms specific to your indication.

Cost-Share Basics & Financial Assistance

Tremfya's specialty tier placement means significant out-of-pocket costs:

  • Typical copay: $50-$200+ per injection (varies by plan)
  • Coinsurance: 25-50% after deductible for many plans
  • Deductible: May apply before coverage begins

Financial Assistance Options

  • TREMFYA withMe Program: Potential $0 copay for eligible commercially insured patients; income restrictions apply
  • Free first dose: Available through manufacturer program while PA is pending
  • Patient assistance foundations: Various nonprofits offer grants for biologic medications

Contact TREMFYA withMe at (844) 494-8463 for eligibility screening.

Step-by-Step: Fastest Path to Approval

  1. Schedule specialist appointment (patient action)
    • Book with in-network dermatologist, rheumatologist, or gastroenterologist
    • Bring insurance card, list of previous treatments, medical records
  2. Gather failure documentation (clinic staff)
    • Pharmacy records showing previous biologic trials
    • Provider notes documenting inadequate response or intolerance
    • Lab results, imaging, severity assessments
  3. Complete TB screening (provider orders)
    • QuantiFERON Gold or TST within 6 months
    • Chest X-ray to rule out active tuberculosis
    • Document negative results in PA submission
  4. Submit prior authorization (provider)
  5. Enroll with CVS Specialty (provider/patient)
    • Complete CVS Specialty enrollment form
    • Fax to (888) 267-3277 or submit online
    • Provide signed patient authorization
  6. Track approval status (patient)
    • Call CVS Specialty at (866) 752-7021 after 2 weeks
    • Request peer-to-peer review if initial denial
    • Prepare appeal documentation if needed
  7. Schedule delivery (CVS Specialty)
    • Coordinate first injection timing
    • Arrange specialty pharmacy delivery
    • Confirm injection training if needed

Common Denial Reasons & How to Fix Them

Denial Reason Fix Strategy Required Documentation
Step therapy not met Document failure of preferred agents Pharmacy records, provider notes showing 3+ months trial with inadequate response
Missing TB screening Complete required testing Negative QuantiFERON/TST within 6 months, chest X-ray results
Insufficient disease severity Provide objective measures PASI scores, BSA calculations, photos, joint counts, inflammatory markers
Non-formulary status Request formulary exception Medical necessity letter explaining why preferred alternatives failed/contraindicated
Quantity limits exceeded Justify dosing frequency FDA labeling, clinical guidelines supporting proposed schedule
"Not medically necessary" Strengthen clinical rationale Peer-reviewed studies, specialty guidelines, detailed treatment history
Tip: Request a peer-to-peer review before formal appeal. Many denials are overturned when the prescribing physician speaks directly with the plan's medical director.

Appeals Process in Texas

Texas law provides robust appeal rights for Aetna CVS Health denials:

Internal Appeals (First Level)

  • Timeline: File within 180 days of denial notice
  • Submission: Email [email protected] or use Availity portal
  • Decision timeframe: 30 days standard; 72 hours expedited (with urgency documentation)
  • Required: Appeal form, denial notice, supporting clinical documentation

External Review (Independent Review Organization)

  • Eligibility: After internal appeal denial for medical necessity disputes
  • Timeline: File within 4 months of final internal denial
  • Process: Texas Department of Insurance assigns independent physicians
  • Success rate: Approximately 60% reversal rate for specialty drug appeals in Texas
  • Cost: Free to patients; insurer pays IRO fees

Expedited Appeals

Available when delays would jeopardize health:

  • Internal expedited: 72 hours with physician urgency letter
  • External expedited: 5 days for emergency cases
  • Concurrent filing: Can file expedited external review alongside internal appeal

File external review requests through Texas Department of Insurance online portal.

Counterforce Health specializes in turning insurance denials into successful appeals by identifying the specific denial basis and crafting evidence-backed rebuttals aligned to each plan's own rules. Their platform helps patients and clinicians navigate complex prior authorization requirements and appeals processes more effectively.

Required Forms & Submission Details

Primary Forms

  1. Aetna Tremfya PA Form: Medicare-specific version available
  2. CVS Specialty Enrollment Form: Condition-specific versions
  3. TREMFYA withMe Enrollment: Patient assistance program form

Key Submission Points

  • Availity portal: Preferred method for PA submissions
  • Fax numbers: (888) 267-3277 for CVS Specialty; (844) 268-7263 for Medicare PA
  • Phone support: (866) 235-5660 for Aetna PA status; (866) 752-7021 for CVS Specialty

Critical Form Fields

  • Complete patient demographics and insurance information
  • Detailed diagnosis codes and clinical severity measures
  • Comprehensive prior therapy history with outcomes
  • Provider signature and NPI (no stamps accepted)
  • TB screening results and dates

FAQ: Your Top Questions Answered

How long does Aetna CVS Health prior authorization take for Tremfya in Texas? Standard decisions take 30-45 days. Expedited reviews are completed within 72 hours when a physician documents that delays would jeopardize the patient's health.

What if Tremfya is not on my Aetna formulary? Request a formulary exception by documenting medical necessity and failure/contraindication to formulary alternatives. Include peer-reviewed literature supporting Tremfya's unique benefits.

Can I appeal if my Texas Aetna plan denies Tremfya? Yes. Texas law guarantees internal appeals (180-day deadline) and independent external review (4-month deadline after final internal denial). External reviews have approximately 60% success rates for specialty biologics.

Does step therapy apply if I failed biologics in another state? Yes, documented failures from any provider/location count toward step therapy requirements. Ensure your new Texas provider has complete records from previous treatments.

What counts as "failure" of a preferred biologic? Typically 3+ months of therapy at appropriate doses with inadequate clinical response, intolerable side effects, or medical contraindications. Document specific outcomes and reasons for discontinuation.

Can I use a different specialty pharmacy instead of CVS? No, Aetna CVS Health typically mandates CVS Specialty for Tremfya dispensing. Using non-network pharmacies may result in no coverage or significantly higher costs.

What if I need Tremfya urgently while appeals are pending? Request expedited internal and external appeals with physician documentation of urgency. Apply for manufacturer assistance programs that may provide temporary supply during appeal processes.

How do I find in-network specialists in Texas for Tremfya prescriptions? Use Aetna's provider directory online or call member services. Ensure the specialist is in-network for your specific plan type (HMO, PPO, or EPO).

This guide provides educational information about insurance coverage and is not medical advice. Coverage decisions depend on individual plan benefits, medical necessity, and clinical circumstances. For personalized guidance, consult your healthcare provider and insurance representative.

Texas Resources:

Sources & Further Reading:

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.